| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatoblastoma | 35 | 2023 | 215 | 5.000 |
Why?
|
| Liver | 133 | 2020 | 2961 | 3.520 |
Why?
|
| Liver Neoplasms | 86 | 2023 | 4557 | 3.300 |
Why?
|
| Liver Diseases | 22 | 2020 | 574 | 2.030 |
Why?
|
| Biliary Atresia | 15 | 2023 | 191 | 1.630 |
Why?
|
| Hepatocytes | 32 | 2020 | 351 | 1.630 |
Why?
|
| Hydrolases | 32 | 2016 | 123 | 1.460 |
Why?
|
| Cholestasis | 13 | 2021 | 203 | 1.350 |
Why?
|
| Carcinoma, Hepatocellular | 31 | 2022 | 2027 | 1.330 |
Why?
|
| Cholestasis, Intrahepatic | 10 | 2021 | 74 | 1.250 |
Why?
|
| Genetic Vectors | 42 | 2014 | 1694 | 1.200 |
Why?
|
| Bilirubin | 10 | 2021 | 221 | 1.120 |
Why?
|
| Liver Transplantation | 27 | 2021 | 1112 | 1.060 |
Why?
|
| Tyrosinemias | 16 | 2014 | 22 | 1.050 |
Why?
|
| Genetic Therapy | 40 | 2012 | 1616 | 0.960 |
Why?
|
| Adenoviridae | 28 | 2014 | 1459 | 0.930 |
Why?
|
| Infant | 80 | 2023 | 13310 | 0.890 |
Why?
|
| Mice | 180 | 2020 | 34495 | 0.710 |
Why?
|
| Liver Regeneration | 14 | 2018 | 134 | 0.700 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 8 | 2018 | 591 | 0.690 |
Why?
|
| Animals | 224 | 2020 | 59536 | 0.680 |
Why?
|
| Pediatrics | 5 | 2016 | 1141 | 0.650 |
Why?
|
| Cell Differentiation | 19 | 2021 | 4078 | 0.640 |
Why?
|
| Child | 81 | 2023 | 29154 | 0.640 |
Why?
|
| Portoenterostomy, Hepatic | 6 | 2020 | 48 | 0.620 |
Why?
|
| Child, Preschool | 62 | 2021 | 16273 | 0.620 |
Why?
|
| Spleen | 15 | 2019 | 676 | 0.610 |
Why?
|
| Mice, Knockout | 55 | 2019 | 5710 | 0.590 |
Why?
|
| Infant, Newborn | 54 | 2021 | 8223 | 0.580 |
Why?
|
| Neoplasms, Complex and Mixed | 2 | 2008 | 43 | 0.560 |
Why?
|
| Pathology, Surgical | 1 | 2016 | 81 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 57 | 2020 | 6942 | 0.540 |
Why?
|
| Copper | 6 | 2017 | 165 | 0.530 |
Why?
|
| Pathology | 2 | 2015 | 101 | 0.530 |
Why?
|
| Mice, Transgenic | 49 | 2020 | 4143 | 0.520 |
Why?
|
| Humans | 242 | 2023 | 261506 | 0.510 |
Why?
|
| Jaundice | 1 | 2015 | 39 | 0.510 |
Why?
|
| Intestine, Small | 9 | 2017 | 499 | 0.500 |
Why?
|
| Male | 179 | 2021 | 123000 | 0.480 |
Why?
|
| Hepatectomy | 13 | 2022 | 1011 | 0.480 |
Why?
|
| Metabolic Diseases | 2 | 2017 | 130 | 0.470 |
Why?
|
| ATP-Binding Cassette Transporters | 4 | 2016 | 299 | 0.470 |
Why?
|
| Dependovirus | 6 | 2016 | 135 | 0.460 |
Why?
|
| Biopsy | 18 | 2019 | 3443 | 0.460 |
Why?
|
| Transduction, Genetic | 19 | 2014 | 475 | 0.460 |
Why?
|
| alpha 1-Antitrypsin | 14 | 2017 | 97 | 0.450 |
Why?
|
| Female | 185 | 2021 | 141928 | 0.450 |
Why?
|
| Tyrosine | 12 | 2010 | 498 | 0.450 |
Why?
|
| Bile Ducts, Intrahepatic | 4 | 2017 | 334 | 0.450 |
Why?
|
| Liver Cirrhosis | 11 | 2019 | 941 | 0.450 |
Why?
|
| Simian virus 40 | 7 | 1999 | 137 | 0.440 |
Why?
|
| Nitrobenzoates | 10 | 2008 | 15 | 0.440 |
Why?
|
| Hamartoma | 4 | 2018 | 115 | 0.430 |
Why?
|
| Stromal Cells | 2 | 2008 | 825 | 0.430 |
Why?
|
| Cyclohexanones | 10 | 2008 | 30 | 0.430 |
Why?
|
| Intestines | 7 | 2016 | 686 | 0.420 |
Why?
|
| Stem Cells | 10 | 2020 | 1213 | 0.420 |
Why?
|
| Adolescent | 47 | 2023 | 31252 | 0.410 |
Why?
|
| Transgenes | 10 | 2013 | 557 | 0.400 |
Why?
|
| Nuclear Proteins | 14 | 2020 | 3343 | 0.400 |
Why?
|
| Cell Transplantation | 9 | 2001 | 85 | 0.390 |
Why?
|
| Liver Failure | 4 | 2020 | 140 | 0.390 |
Why?
|
| Epithelial Cells | 5 | 2023 | 1818 | 0.390 |
Why?
|
| Kidney Tubules, Proximal | 3 | 2008 | 142 | 0.380 |
Why?
|
| Disease Models, Animal | 38 | 2020 | 7222 | 0.370 |
Why?
|
| DNA, Viral | 14 | 2012 | 694 | 0.370 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 19 | 2023 | 15862 | 0.350 |
Why?
|
| Helper Viruses | 9 | 2013 | 55 | 0.350 |
Why?
|
| SOX9 Transcription Factor | 4 | 2020 | 170 | 0.350 |
Why?
|
| Gene Transfer Techniques | 16 | 2012 | 716 | 0.350 |
Why?
|
| Societies, Medical | 1 | 2015 | 1335 | 0.350 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 4 | 1998 | 105 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2019 | 1498 | 0.340 |
Why?
|
| Fatty Liver | 6 | 2019 | 235 | 0.330 |
Why?
|
| DNA Transposable Elements | 3 | 2018 | 222 | 0.330 |
Why?
|
| Neonatal Screening | 3 | 2020 | 165 | 0.330 |
Why?
|
| Vincristine | 12 | 2023 | 1511 | 0.320 |
Why?
|
| Cell Lineage | 6 | 2020 | 668 | 0.320 |
Why?
|
| Diarrhea | 5 | 2016 | 686 | 0.310 |
Why?
|
| Transcription Factors | 12 | 2019 | 5270 | 0.300 |
Why?
|
| Immunohistochemistry | 27 | 2019 | 7548 | 0.300 |
Why?
|
| Histological Techniques | 1 | 2007 | 65 | 0.300 |
Why?
|
| Cells, Cultured | 27 | 2019 | 5637 | 0.300 |
Why?
|
| Adenoma | 3 | 2008 | 716 | 0.290 |
Why?
|
| Inhibins | 7 | 1996 | 128 | 0.290 |
Why?
|
| Rotavirus Infections | 5 | 2012 | 287 | 0.290 |
Why?
|
| Enzyme Inhibitors | 10 | 2012 | 1879 | 0.290 |
Why?
|
| Carcinoma | 5 | 2015 | 2578 | 0.290 |
Why?
|
| Tumor Virus Infections | 3 | 1999 | 224 | 0.280 |
Why?
|
| DNA-Binding Proteins | 13 | 2019 | 4821 | 0.280 |
Why?
|
| Cell Separation | 8 | 2014 | 612 | 0.270 |
Why?
|
| Neoplasm Proteins | 7 | 2019 | 3230 | 0.270 |
Why?
|
| Beckwith-Wiedemann Syndrome | 3 | 2016 | 38 | 0.270 |
Why?
|
| Aldehyde Reductase | 1 | 2005 | 60 | 0.260 |
Why?
|
| Liver Neoplasms, Experimental | 6 | 2014 | 196 | 0.260 |
Why?
|
| Regeneration | 3 | 2020 | 279 | 0.250 |
Why?
|
| Mutation | 16 | 2022 | 15179 | 0.250 |
Why?
|
| Iron | 2 | 2019 | 376 | 0.250 |
Why?
|
| Animals, Newborn | 18 | 2012 | 1338 | 0.250 |
Why?
|
| Bile Duct Neoplasms | 3 | 2020 | 493 | 0.250 |
Why?
|
| Cholangiocarcinoma | 3 | 2020 | 493 | 0.250 |
Why?
|
| GTP-Binding Proteins | 4 | 2020 | 321 | 0.250 |
Why?
|
| Wnt Proteins | 3 | 2014 | 397 | 0.250 |
Why?
|
| Cisplatin | 11 | 2021 | 2432 | 0.250 |
Why?
|
| beta Catenin | 4 | 2016 | 688 | 0.250 |
Why?
|
| DNA Damage | 9 | 2020 | 1954 | 0.250 |
Why?
|
| Fanconi Anemia | 4 | 2008 | 88 | 0.240 |
Why?
|
| Cystic Fibrosis | 4 | 2019 | 264 | 0.240 |
Why?
|
| History, 21st Century | 2 | 2016 | 441 | 0.240 |
Why?
|
| Rhabdoid Tumor | 3 | 2010 | 110 | 0.240 |
Why?
|
| Base Sequence | 25 | 2013 | 4917 | 0.240 |
Why?
|
| Mutagenesis | 7 | 2018 | 483 | 0.240 |
Why?
|
| Cholangitis | 3 | 2018 | 48 | 0.240 |
Why?
|
| Abnormalities, Multiple | 9 | 2019 | 998 | 0.230 |
Why?
|
| Cell Cycle Proteins | 9 | 2018 | 2045 | 0.230 |
Why?
|
| History, 20th Century | 2 | 2016 | 574 | 0.230 |
Why?
|
| Up-Regulation | 6 | 2020 | 2450 | 0.230 |
Why?
|
| Hepatolenticular Degeneration | 3 | 2015 | 44 | 0.230 |
Why?
|
| Polycystic Kidney Diseases | 3 | 2019 | 34 | 0.230 |
Why?
|
| Sarcoma | 2 | 2016 | 1725 | 0.230 |
Why?
|
| Gene Expression | 21 | 2013 | 3570 | 0.220 |
Why?
|
| Adenoma, Liver Cell | 2 | 2016 | 17 | 0.220 |
Why?
|
| Bile Ducts | 10 | 2020 | 113 | 0.220 |
Why?
|
| Liver Glycogen | 3 | 2020 | 31 | 0.210 |
Why?
|
| Factor IX | 5 | 2012 | 30 | 0.210 |
Why?
|
| Fetus | 8 | 2011 | 601 | 0.210 |
Why?
|
| Epithelium | 7 | 2023 | 720 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2020 | 8873 | 0.210 |
Why?
|
| Fluorouracil | 9 | 2019 | 1944 | 0.210 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2016 | 551 | 0.210 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2018 | 421 | 0.210 |
Why?
|
| 1,4-alpha-Glucan Branching Enzyme | 2 | 2012 | 7 | 0.210 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 778 | 0.210 |
Why?
|
| Glycogen Storage Disease Type IV | 2 | 2012 | 10 | 0.210 |
Why?
|
| alpha-Fetoproteins | 8 | 2023 | 237 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2013 | 2488 | 0.210 |
Why?
|
| Heterozygote | 11 | 2020 | 1020 | 0.210 |
Why?
|
| Carcinogenesis | 4 | 2018 | 1026 | 0.200 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 3 | 2017 | 40 | 0.200 |
Why?
|
| Aneuploidy | 4 | 2012 | 369 | 0.200 |
Why?
|
| Virus Integration | 2 | 2012 | 76 | 0.200 |
Why?
|
| Lung | 15 | 2016 | 3151 | 0.200 |
Why?
|
| Penicillamine | 2 | 2010 | 22 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 16 | 2020 | 3101 | 0.200 |
Why?
|
| Fetal Death | 3 | 2019 | 113 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2016 | 249 | 0.190 |
Why?
|
| Colitis | 3 | 2014 | 340 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 848 | 0.190 |
Why?
|
| Time Factors | 18 | 2021 | 12926 | 0.190 |
Why?
|
| beta-Galactosidase | 11 | 2009 | 211 | 0.190 |
Why?
|
| Phosphoproteins | 3 | 2018 | 1152 | 0.190 |
Why?
|
| Catheterization | 3 | 2012 | 410 | 0.180 |
Why?
|
| Organotin Compounds | 1 | 2020 | 8 | 0.180 |
Why?
|
| Herpesvirus 4, Human | 5 | 2006 | 966 | 0.180 |
Why?
|
| Retroviridae | 11 | 2006 | 332 | 0.180 |
Why?
|
| Signal Transduction | 18 | 2020 | 11965 | 0.180 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2019 | 186 | 0.180 |
Why?
|
| Argininosuccinate Lyase | 1 | 2020 | 66 | 0.180 |
Why?
|
| Liver Cirrhosis, Biliary | 2 | 2018 | 78 | 0.180 |
Why?
|
| Alagille Syndrome | 1 | 2020 | 44 | 0.180 |
Why?
|
| Hepatitis | 6 | 2010 | 93 | 0.180 |
Why?
|
| Siderosis | 1 | 2019 | 2 | 0.170 |
Why?
|
| Intestinal Mucosa | 7 | 2006 | 1081 | 0.170 |
Why?
|
| Bile Acids and Salts | 4 | 2016 | 246 | 0.170 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2019 | 10 | 0.170 |
Why?
|
| Probiotics | 2 | 2012 | 228 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 1439 | 0.170 |
Why?
|
| Sirtuins | 1 | 2019 | 44 | 0.170 |
Why?
|
| Hemophilia B | 3 | 2012 | 14 | 0.170 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 83 | 0.170 |
Why?
|
| Parenteral Nutrition | 3 | 2012 | 207 | 0.170 |
Why?
|
| Adaptation, Physiological | 3 | 2012 | 360 | 0.170 |
Why?
|
| 4-Hydroxyphenylpyruvate Dioxygenase | 1 | 1998 | 1 | 0.170 |
Why?
|
| Phenotype | 22 | 2020 | 6295 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 14 | 2012 | 3203 | 0.170 |
Why?
|
| Thymidine Kinase | 7 | 1997 | 193 | 0.170 |
Why?
|
| Cell Proliferation | 13 | 2020 | 7226 | 0.170 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 3 | 2005 | 37 | 0.170 |
Why?
|
| Telomere Shortening | 1 | 2019 | 56 | 0.170 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 181 | 0.160 |
Why?
|
| Growth | 3 | 2009 | 117 | 0.160 |
Why?
|
| Dietary Fats | 3 | 2011 | 339 | 0.160 |
Why?
|
| Graft Rejection | 2 | 2017 | 834 | 0.160 |
Why?
|
| Xenobiotics | 1 | 2018 | 44 | 0.160 |
Why?
|
| Pancreas | 4 | 2014 | 718 | 0.160 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2011 | 210 | 0.160 |
Why?
|
| Chemotherapy, Adjuvant | 10 | 2022 | 3890 | 0.160 |
Why?
|
| Heterotaxy Syndrome | 1 | 2018 | 63 | 0.160 |
Why?
|
| Histocytochemistry | 7 | 2016 | 185 | 0.160 |
Why?
|
| Uteroglobin | 5 | 2003 | 54 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 246 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2012 | 363 | 0.160 |
Why?
|
| Organoids | 3 | 2017 | 287 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2008 | 528 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2015 | 10035 | 0.160 |
Why?
|
| Transplantation, Heterotopic | 3 | 1996 | 43 | 0.160 |
Why?
|
| Biliary Tract | 4 | 2018 | 37 | 0.150 |
Why?
|
| Hepatocyte Growth Factor | 3 | 2013 | 142 | 0.150 |
Why?
|
| Enterocytes | 4 | 2012 | 68 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 3 | 2016 | 1130 | 0.150 |
Why?
|
| Pancreas Transplantation | 1 | 2017 | 46 | 0.150 |
Why?
|
| Trans-Activators | 6 | 2006 | 1555 | 0.150 |
Why?
|
| Bone Marrow Transplantation | 5 | 2005 | 1581 | 0.150 |
Why?
|
| Gene Expression Profiling | 9 | 2017 | 5159 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2005 | 582 | 0.150 |
Why?
|
| Sjogren's Syndrome | 1 | 1998 | 102 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2019 | 1064 | 0.150 |
Why?
|
| Early Diagnosis | 1 | 2018 | 298 | 0.150 |
Why?
|
| Genomic Instability | 1 | 2020 | 519 | 0.150 |
Why?
|
| Carrier Proteins | 3 | 2016 | 2022 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 144 | 0.140 |
Why?
|
| Antigens, Polyomavirus Transforming | 5 | 1997 | 110 | 0.140 |
Why?
|
| Cell Cycle | 6 | 2015 | 2084 | 0.140 |
Why?
|
| Repressor Proteins | 3 | 2016 | 1664 | 0.140 |
Why?
|
| Antioxidants | 3 | 2010 | 507 | 0.140 |
Why?
|
| Premature Birth | 1 | 2021 | 407 | 0.140 |
Why?
|
| Germinal Center | 1 | 2017 | 161 | 0.140 |
Why?
|
| Portal System | 1 | 1996 | 34 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2018 | 2359 | 0.140 |
Why?
|
| Hemangiosarcoma | 3 | 2014 | 234 | 0.140 |
Why?
|
| Needles | 1 | 1997 | 107 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2004 | 1242 | 0.140 |
Why?
|
| Chromosomes | 2 | 2010 | 244 | 0.140 |
Why?
|
| Receptors, Purinergic P2X3 | 1 | 2015 | 4 | 0.140 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 3 | 2016 | 328 | 0.140 |
Why?
|
| Antigens, Viral, Tumor | 5 | 1997 | 47 | 0.140 |
Why?
|
| Receptors, LDL | 2 | 2010 | 109 | 0.140 |
Why?
|
| Circadian Clocks | 1 | 2016 | 66 | 0.140 |
Why?
|
| Diagnosis, Differential | 10 | 2016 | 4744 | 0.140 |
Why?
|
| Proteins | 7 | 2010 | 1963 | 0.140 |
Why?
|
| Pregnancy | 20 | 2021 | 7573 | 0.140 |
Why?
|
| Zonula Occludens-2 Protein | 1 | 2015 | 8 | 0.140 |
Why?
|
| Doxorubicin | 6 | 2021 | 3005 | 0.130 |
Why?
|
| Niemann-Pick Diseases | 2 | 1994 | 4 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2004 | 220 | 0.130 |
Why?
|
| Treatment Outcome | 18 | 2023 | 32848 | 0.130 |
Why?
|
| RNA, Messenger | 16 | 2011 | 6150 | 0.130 |
Why?
|
| Aging | 8 | 2010 | 1582 | 0.130 |
Why?
|
| Retrospective Studies | 15 | 2021 | 37905 | 0.130 |
Why?
|
| Biomarkers | 12 | 2017 | 5047 | 0.130 |
Why?
|
| DNA | 14 | 2005 | 2693 | 0.130 |
Why?
|
| Body Weight | 5 | 2018 | 1293 | 0.130 |
Why?
|
| Afibrinogenemia | 1 | 2015 | 10 | 0.130 |
Why?
|
| Disease-Free Survival | 8 | 2017 | 10001 | 0.130 |
Why?
|
| Gram-Negative Aerobic Bacteria | 1 | 1995 | 5 | 0.130 |
Why?
|
| Membrane Proteins | 6 | 2019 | 2819 | 0.130 |
Why?
|
| Bartonella | 1 | 1995 | 13 | 0.130 |
Why?
|
| Cell Division | 14 | 2002 | 2489 | 0.130 |
Why?
|
| Abdomen | 2 | 1997 | 332 | 0.130 |
Why?
|
| Cell Fusion | 5 | 2009 | 80 | 0.130 |
Why?
|
| Gene Expression Regulation | 13 | 2017 | 4053 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 4 | 2009 | 8 | 0.130 |
Why?
|
| Cough | 1 | 2016 | 116 | 0.130 |
Why?
|
| Hepatitis B virus | 5 | 2001 | 217 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2013 | 589 | 0.130 |
Why?
|
| Gene Targeting | 4 | 2012 | 292 | 0.130 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2014 | 12 | 0.130 |
Why?
|
| Hepatic Duct, Common | 4 | 2023 | 16 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2006 | 1016 | 0.130 |
Why?
|
| Receptors, Lipoprotein | 1 | 2014 | 16 | 0.130 |
Why?
|
| Cat-Scratch Disease | 1 | 1995 | 35 | 0.130 |
Why?
|
| Glycogen Storage Disease | 1 | 1994 | 11 | 0.130 |
Why?
|
| Rotavirus | 4 | 2012 | 377 | 0.130 |
Why?
|
| Receptors, Notch | 4 | 2020 | 383 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2015 | 143 | 0.120 |
Why?
|
| Cyclins | 3 | 2004 | 456 | 0.120 |
Why?
|
| Stomach | 2 | 1997 | 387 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2013 | 29 | 0.120 |
Why?
|
| Reproduction | 2 | 1996 | 253 | 0.120 |
Why?
|
| Rats | 21 | 2006 | 6086 | 0.120 |
Why?
|
| Gene Knockout Techniques | 2 | 2014 | 276 | 0.120 |
Why?
|
| Kupffer Cells | 2 | 2012 | 42 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 1443 | 0.120 |
Why?
|
| Flow Cytometry | 7 | 2017 | 3033 | 0.120 |
Why?
|
| Wilms Tumor | 4 | 1999 | 292 | 0.120 |
Why?
|
| Wnt Signaling Pathway | 2 | 2016 | 430 | 0.120 |
Why?
|
| Papillomavirus Infections | 2 | 1999 | 980 | 0.120 |
Why?
|
| Metagenome | 2 | 2012 | 176 | 0.120 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 73 | 0.120 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2013 | 30 | 0.120 |
Why?
|
| Cholesterol | 3 | 2006 | 658 | 0.120 |
Why?
|
| Hepatitis C | 3 | 2015 | 524 | 0.120 |
Why?
|
| Colitis, Ulcerative | 3 | 2011 | 268 | 0.120 |
Why?
|
| Carbocyanines | 2 | 1992 | 41 | 0.120 |
Why?
|
| Risk Factors | 6 | 2021 | 17523 | 0.120 |
Why?
|
| Pulmonary Alveoli | 5 | 2011 | 208 | 0.120 |
Why?
|
| Disease Progression | 3 | 2021 | 6682 | 0.120 |
Why?
|
| Molecular Sequence Data | 18 | 2013 | 6089 | 0.120 |
Why?
|
| Transfection | 7 | 2005 | 2944 | 0.120 |
Why?
|
| Fetal Diseases | 4 | 1992 | 388 | 0.120 |
Why?
|
| Recombinant Proteins | 13 | 2012 | 2927 | 0.120 |
Why?
|
| Transplant Recipients | 1 | 2016 | 324 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2015 | 3639 | 0.120 |
Why?
|
| Multigene Family | 1 | 2015 | 425 | 0.120 |
Why?
|
| Apoptosis | 10 | 2018 | 7591 | 0.120 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 279 | 0.120 |
Why?
|
| Biomarkers, Tumor | 6 | 2020 | 10331 | 0.120 |
Why?
|
| Teratoma | 2 | 2015 | 236 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2015 | 489 | 0.110 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 104 | 0.110 |
Why?
|
| Enkephalin, Methionine | 1 | 2012 | 11 | 0.110 |
Why?
|
| Young Adult | 8 | 2023 | 21445 | 0.110 |
Why?
|
| Tissue Distribution | 8 | 2005 | 875 | 0.110 |
Why?
|
| Diseases in Twins | 1 | 2013 | 99 | 0.110 |
Why?
|
| Opioid Peptides | 1 | 2012 | 9 | 0.110 |
Why?
|
| Swine | 4 | 2014 | 1541 | 0.110 |
Why?
|
| Postoperative Complications | 5 | 2019 | 5542 | 0.110 |
Why?
|
| Prenatal Diagnosis | 2 | 1997 | 590 | 0.110 |
Why?
|
| Waardenburg Syndrome | 1 | 2012 | 11 | 0.110 |
Why?
|
| Epigenesis, Genetic | 2 | 2010 | 1399 | 0.110 |
Why?
|
| Twins, Monozygotic | 1 | 2013 | 129 | 0.110 |
Why?
|
| Norovirus | 1 | 2016 | 287 | 0.110 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 2010 | 28 | 0.110 |
Why?
|
| Macaca mulatta | 2 | 2012 | 717 | 0.110 |
Why?
|
| Age Factors | 10 | 2020 | 5377 | 0.110 |
Why?
|
| Alkaptonuria | 1 | 2012 | 1 | 0.110 |
Why?
|
| Glutathione | 4 | 2008 | 368 | 0.110 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 2173 | 0.110 |
Why?
|
| Rectal Fistula | 1 | 1992 | 5 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 487 | 0.110 |
Why?
|
| Megacolon | 1 | 1992 | 6 | 0.110 |
Why?
|
| Urinary Bladder Fistula | 1 | 1992 | 13 | 0.110 |
Why?
|
| Interleukin-2 | 5 | 1997 | 842 | 0.110 |
Why?
|
| Benzaldehydes | 1 | 2012 | 11 | 0.110 |
Why?
|
| Papio | 6 | 2013 | 70 | 0.110 |
Why?
|
| DNA, Bacterial | 1 | 1995 | 558 | 0.110 |
Why?
|
| DNA, Ribosomal | 1 | 2012 | 103 | 0.110 |
Why?
|
| Neoplasm Staging | 5 | 2021 | 13658 | 0.110 |
Why?
|
| Short Bowel Syndrome | 1 | 2012 | 60 | 0.110 |
Why?
|
| Oligohydramnios | 1 | 1992 | 37 | 0.110 |
Why?
|
| Cell Movement | 5 | 2016 | 2466 | 0.110 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2012 | 12 | 0.110 |
Why?
|
| Enteritis | 1 | 2012 | 65 | 0.110 |
Why?
|
| Polyploidy | 2 | 2010 | 73 | 0.110 |
Why?
|
| Alanine Transaminase | 5 | 2020 | 227 | 0.110 |
Why?
|
| Crohn Disease | 1 | 2016 | 351 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2019 | 703 | 0.110 |
Why?
|
| Staining and Labeling | 3 | 1992 | 429 | 0.100 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2003 | 467 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2014 | 170 | 0.100 |
Why?
|
| Thyroid Gland | 5 | 1994 | 355 | 0.100 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2011 | 5 | 0.100 |
Why?
|
| Urethra | 1 | 1992 | 144 | 0.100 |
Why?
|
| Phenylalanine Hydroxylase | 3 | 2005 | 25 | 0.100 |
Why?
|
| Enterococcus | 1 | 2012 | 59 | 0.100 |
Why?
|
| Syndrome | 12 | 2019 | 1351 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2014 | 726 | 0.100 |
Why?
|
| CCAAT-Binding Factor | 1 | 2011 | 34 | 0.100 |
Why?
|
| Colonic Neoplasms | 5 | 2000 | 1390 | 0.100 |
Why?
|
| DNA End-Joining Repair | 1 | 2012 | 86 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2021 | 6869 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2016 | 698 | 0.100 |
Why?
|
| Neuroblastoma | 2 | 2015 | 686 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 6 | 2011 | 1165 | 0.100 |
Why?
|
| Mice, Inbred Strains | 8 | 2013 | 521 | 0.100 |
Why?
|
| Cell Survival | 10 | 2017 | 3045 | 0.100 |
Why?
|
| Reference Values | 3 | 2020 | 1099 | 0.100 |
Why?
|
| Anal Canal | 1 | 1992 | 238 | 0.100 |
Why?
|
| Lymph Nodes | 3 | 2008 | 2967 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2011 | 96 | 0.100 |
Why?
|
| Phenylketonurias | 2 | 2005 | 23 | 0.100 |
Why?
|
| Fluorescent Dyes | 2 | 1992 | 459 | 0.100 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2010 | 36 | 0.100 |
Why?
|
| Rabbits | 8 | 1999 | 957 | 0.100 |
Why?
|
| Osteopontin | 1 | 2011 | 148 | 0.100 |
Why?
|
| Adrenal Glands | 6 | 1994 | 122 | 0.100 |
Why?
|
| Bone Marrow Cells | 3 | 2004 | 943 | 0.100 |
Why?
|
| Appendix | 1 | 2011 | 41 | 0.100 |
Why?
|
| Recombination, Genetic | 4 | 2012 | 613 | 0.090 |
Why?
|
| Lipid Metabolism | 3 | 2011 | 483 | 0.090 |
Why?
|
| Simplexvirus | 5 | 1997 | 159 | 0.090 |
Why?
|
| Eosinophilia | 1 | 2012 | 176 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2005 | 327 | 0.090 |
Why?
|
| Smad4 Protein | 1 | 2012 | 196 | 0.090 |
Why?
|
| Models, Genetic | 4 | 2010 | 1113 | 0.090 |
Why?
|
| Adenoviruses, Human | 2 | 2006 | 181 | 0.090 |
Why?
|
| Sensitivity and Specificity | 6 | 2020 | 4971 | 0.090 |
Why?
|
| Zinc Sulfate | 1 | 2010 | 8 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 203 | 0.090 |
Why?
|
| Glucose-6-Phosphatase | 2 | 2008 | 23 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 973 | 0.090 |
Why?
|
| DNA Primers | 7 | 2012 | 1399 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2012 | 337 | 0.090 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 294 | 0.090 |
Why?
|
| Cation Transport Proteins | 2 | 2015 | 199 | 0.090 |
Why?
|
| Kidney | 8 | 2008 | 2146 | 0.090 |
Why?
|
| Viremia | 2 | 2011 | 177 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2011 | 862 | 0.090 |
Why?
|
| Food Hypersensitivity | 1 | 2012 | 135 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2010 | 148 | 0.090 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2009 | 54 | 0.090 |
Why?
|
| Spectrin | 1 | 2010 | 85 | 0.090 |
Why?
|
| Amifostine | 1 | 2009 | 97 | 0.090 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 14551 | 0.090 |
Why?
|
| Sirolimus | 1 | 2014 | 814 | 0.090 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 4320 | 0.090 |
Why?
|
| Chronic Disease | 5 | 2020 | 1819 | 0.090 |
Why?
|
| Chelating Agents | 1 | 2010 | 127 | 0.090 |
Why?
|
| Nucleic Acid Probes | 1 | 1989 | 2 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 488 | 0.090 |
Why?
|
| Radiation-Protective Agents | 1 | 2009 | 128 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2015 | 1301 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2010 | 231 | 0.090 |
Why?
|
| Clone Cells | 4 | 2014 | 555 | 0.090 |
Why?
|
| Diethylnitrosamine | 2 | 2001 | 36 | 0.090 |
Why?
|
| Multipotent Stem Cells | 2 | 2013 | 52 | 0.090 |
Why?
|
| Carboplatin | 3 | 2009 | 823 | 0.080 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2008 | 18 | 0.080 |
Why?
|
| Adenosine Triphosphatases | 2 | 2015 | 435 | 0.080 |
Why?
|
| Homogentisic Acid | 2 | 2005 | 2 | 0.080 |
Why?
|
| Genetic Variation | 4 | 2019 | 2086 | 0.080 |
Why?
|
| Gastritis | 1 | 2012 | 373 | 0.080 |
Why?
|
| Macrophages | 4 | 2006 | 1304 | 0.080 |
Why?
|
| Karyotyping | 7 | 2010 | 1022 | 0.080 |
Why?
|
| Mice, Mutant Strains | 6 | 2016 | 634 | 0.080 |
Why?
|
| Acetyltransferases | 1 | 2009 | 143 | 0.080 |
Why?
|
| Microdissection | 1 | 2009 | 86 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2015 | 1226 | 0.080 |
Why?
|
| Molecular Chaperones | 2 | 2000 | 264 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2012 | 492 | 0.080 |
Why?
|
| Appendicitis | 1 | 2011 | 169 | 0.080 |
Why?
|
| Ploidies | 1 | 2009 | 248 | 0.080 |
Why?
|
| Exome | 1 | 2014 | 1239 | 0.080 |
Why?
|
| Urinary Bladder | 2 | 2010 | 575 | 0.080 |
Why?
|
| Prognosis | 9 | 2022 | 21713 | 0.080 |
Why?
|
| Immune System Diseases | 1 | 1989 | 65 | 0.080 |
Why?
|
| Chromosome Aberrations | 4 | 2022 | 1960 | 0.080 |
Why?
|
| Carbamazepine | 1 | 2008 | 49 | 0.080 |
Why?
|
| Antigens, Viral | 5 | 2016 | 471 | 0.080 |
Why?
|
| Hep G2 Cells | 3 | 2016 | 155 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 2006 | 221 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 554 | 0.080 |
Why?
|
| Hearing Loss | 1 | 2009 | 153 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 7551 | 0.080 |
Why?
|
| Lasers | 1 | 2009 | 198 | 0.080 |
Why?
|
| Insulin | 5 | 2014 | 1454 | 0.080 |
Why?
|
| Fetal Growth Retardation | 1 | 2009 | 194 | 0.080 |
Why?
|
| Growth Disorders | 1 | 2009 | 218 | 0.080 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2011 | 413 | 0.080 |
Why?
|
| Cyclic N-Oxides | 1 | 2008 | 106 | 0.080 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1990 | 323 | 0.080 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2007 | 47 | 0.080 |
Why?
|
| Insulin-Like Growth Factor II | 3 | 2016 | 107 | 0.080 |
Why?
|
| fas Receptor | 2 | 2006 | 185 | 0.080 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2010 | 383 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 1375 | 0.080 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2008 | 168 | 0.080 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2008 | 145 | 0.080 |
Why?
|
| Cytomegalovirus Infections | 2 | 2000 | 462 | 0.080 |
Why?
|
| Hepatitis, Alcoholic | 1 | 1987 | 20 | 0.080 |
Why?
|
| Actins | 1 | 2010 | 608 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2007 | 131 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2015 | 2669 | 0.070 |
Why?
|
| Hemangioma | 2 | 1986 | 154 | 0.070 |
Why?
|
| Thymus Gland | 3 | 2005 | 294 | 0.070 |
Why?
|
| Colon | 2 | 2010 | 670 | 0.070 |
Why?
|
| Hypoalphalipoproteinemias | 1 | 2006 | 2 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2018 | 2232 | 0.070 |
Why?
|
| Oxidative Stress | 6 | 2010 | 1129 | 0.070 |
Why?
|
| Radiography | 6 | 2016 | 1904 | 0.070 |
Why?
|
| Parenteral Nutrition, Total | 3 | 1987 | 140 | 0.070 |
Why?
|
| Homogentisate 1,2-Dioxygenase | 3 | 2012 | 3 | 0.070 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 4 | 1994 | 118 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 577 | 0.070 |
Why?
|
| Gonadal Dysgenesis | 1 | 1986 | 3 | 0.070 |
Why?
|
| Kidney Neoplasms | 6 | 2008 | 3022 | 0.070 |
Why?
|
| Hepatitis, Viral, Human | 2 | 2000 | 58 | 0.070 |
Why?
|
| Apolipoprotein A-I | 1 | 2006 | 84 | 0.070 |
Why?
|
| Cytokines | 5 | 2012 | 2809 | 0.070 |
Why?
|
| Dysgerminoma | 1 | 1986 | 42 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2006 | 229 | 0.070 |
Why?
|
| Dichloroacetic Acid | 1 | 2006 | 15 | 0.070 |
Why?
|
| Transplantation Immunology | 1 | 2006 | 97 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 1162 | 0.070 |
Why?
|
| Gestational Age | 4 | 2021 | 1069 | 0.070 |
Why?
|
| Testicular Neoplasms | 6 | 1996 | 529 | 0.070 |
Why?
|
| Splanchnic Circulation | 1 | 1986 | 53 | 0.070 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2006 | 37 | 0.070 |
Why?
|
| Hypertension, Portal | 2 | 1991 | 124 | 0.070 |
Why?
|
| Interleukin-10 | 1 | 2009 | 478 | 0.070 |
Why?
|
| Corn Oil | 1 | 2005 | 15 | 0.070 |
Why?
|
| Receptors, Glucagon | 1 | 2006 | 36 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 4892 | 0.070 |
Why?
|
| Fibroblasts | 6 | 2011 | 1682 | 0.070 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2005 | 156 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5178 | 0.070 |
Why?
|
| Eye Abnormalities | 2 | 1986 | 118 | 0.070 |
Why?
|
| Plasmids | 5 | 2012 | 837 | 0.070 |
Why?
|
| Hyperbilirubinemia | 2 | 2005 | 78 | 0.070 |
Why?
|
| Transcription, Genetic | 7 | 2010 | 3154 | 0.070 |
Why?
|
| Arteriovenous Malformations | 1 | 1986 | 70 | 0.070 |
Why?
|
| Sex Differentiation | 2 | 1996 | 41 | 0.070 |
Why?
|
| Injections | 3 | 2007 | 285 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2020 | 2074 | 0.070 |
Why?
|
| Mitochondria, Liver | 2 | 2019 | 49 | 0.070 |
Why?
|
| Umbilical Veins | 3 | 1993 | 115 | 0.070 |
Why?
|
| Cystadenocarcinoma, Mucinous | 1 | 2005 | 21 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2015 | 7702 | 0.070 |
Why?
|
| Sucrose | 1 | 2005 | 64 | 0.070 |
Why?
|
| Microscopy, Electron | 11 | 2001 | 600 | 0.070 |
Why?
|
| Chromosome Deletion | 1 | 2010 | 1005 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2009 | 769 | 0.070 |
Why?
|
| Lymphocyte Transfusion | 1 | 2006 | 175 | 0.070 |
Why?
|
| Hydantoins | 1 | 2005 | 6 | 0.070 |
Why?
|
| Testicular Hormones | 2 | 1995 | 20 | 0.070 |
Why?
|
| Ureteral Obstruction | 2 | 1985 | 143 | 0.070 |
Why?
|
| Hemochromatosis | 1 | 2005 | 35 | 0.070 |
Why?
|
| Neoplasms | 4 | 2016 | 15193 | 0.070 |
Why?
|
| Fluorenes | 1 | 2005 | 17 | 0.070 |
Why?
|
| Alleles | 5 | 2017 | 2437 | 0.070 |
Why?
|
| Splenic Neoplasms | 1 | 1986 | 119 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 3 | 2013 | 62 | 0.070 |
Why?
|
| Hepatomegaly | 2 | 2018 | 69 | 0.070 |
Why?
|
| Failure to Thrive | 1 | 1985 | 91 | 0.070 |
Why?
|
| Placenta | 3 | 2004 | 516 | 0.070 |
Why?
|
| Phenylalanine | 1 | 2005 | 142 | 0.060 |
Why?
|
| Models, Biological | 5 | 2020 | 3254 | 0.060 |
Why?
|
| Cell Line | 9 | 2016 | 5114 | 0.060 |
Why?
|
| Heterografts | 2 | 2019 | 733 | 0.060 |
Why?
|
| Hepatitis B Virus, Woodchuck | 1 | 2004 | 2 | 0.060 |
Why?
|
| Growth Inhibitors | 2 | 1995 | 149 | 0.060 |
Why?
|
| Rhabdomyosarcoma | 1 | 2008 | 341 | 0.060 |
Why?
|
| Blotting, Southern | 5 | 2011 | 406 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2007 | 396 | 0.060 |
Why?
|
| Plague | 3 | 1969 | 15 | 0.060 |
Why?
|
| Dietary Carbohydrates | 1 | 2005 | 134 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2016 | 2947 | 0.060 |
Why?
|
| Necrosis | 7 | 2005 | 580 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2007 | 269 | 0.060 |
Why?
|
| Muscle Hypotonia | 1 | 1985 | 180 | 0.060 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2004 | 34 | 0.060 |
Why?
|
| Kidney Diseases | 2 | 2005 | 691 | 0.060 |
Why?
|
| Mesoderm | 2 | 2018 | 404 | 0.060 |
Why?
|
| Camptothecin | 2 | 2017 | 517 | 0.060 |
Why?
|
| Antigens, Neoplasm | 2 | 2010 | 1506 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2019 | 1489 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2008 | 431 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 598 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2015 | 3536 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2005 | 104 | 0.060 |
Why?
|
| Physical Conditioning, Animal | 1 | 2005 | 112 | 0.060 |
Why?
|
| Telomerase | 2 | 2019 | 525 | 0.060 |
Why?
|
| Genes, Immediate-Early | 1 | 2003 | 9 | 0.060 |
Why?
|
| Gene Deletion | 5 | 2003 | 1442 | 0.060 |
Why?
|
| Adiposity | 2 | 2020 | 237 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1491 | 0.060 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2004 | 54 | 0.060 |
Why?
|
| Cyclin D1 | 2 | 2010 | 576 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2012 | 1589 | 0.060 |
Why?
|
| Cachexia | 2 | 1996 | 161 | 0.060 |
Why?
|
| Sarcoma, Synovial | 1 | 2005 | 119 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2006 | 1538 | 0.060 |
Why?
|
| Brain Neoplasms | 2 | 1997 | 4849 | 0.060 |
Why?
|
| Phosphorylation | 5 | 2011 | 4804 | 0.060 |
Why?
|
| Activins | 4 | 1996 | 98 | 0.060 |
Why?
|
| Fatty Acid Synthases | 1 | 2003 | 24 | 0.060 |
Why?
|
| Models, Animal | 3 | 2012 | 664 | 0.060 |
Why?
|
| Chromosome Mapping | 2 | 2005 | 1471 | 0.060 |
Why?
|
| Drosophila Proteins | 2 | 2000 | 858 | 0.060 |
Why?
|
| Integrases | 1 | 2005 | 262 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2018 | 1681 | 0.060 |
Why?
|
| DNA, Recombinant | 4 | 1999 | 121 | 0.060 |
Why?
|
| Hybrid Cells | 1 | 2003 | 128 | 0.060 |
Why?
|
| F-Box Proteins | 1 | 2004 | 96 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 5 | 2006 | 4367 | 0.060 |
Why?
|
| Hyperplasia | 5 | 2013 | 557 | 0.060 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2008 | 519 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 3578 | 0.060 |
Why?
|
| Radiation Effects | 3 | 1969 | 20 | 0.060 |
Why?
|
| Herpesviridae Infections | 2 | 2000 | 175 | 0.060 |
Why?
|
| Survival Analysis | 4 | 2011 | 9180 | 0.060 |
Why?
|
| Glycoproteins | 3 | 1995 | 747 | 0.060 |
Why?
|
| Barrett Esophagus | 1 | 2009 | 569 | 0.060 |
Why?
|
| Adenocarcinoma | 7 | 1998 | 7789 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1945 | 0.060 |
Why?
|
| Viral Regulatory and Accessory Proteins | 5 | 2006 | 64 | 0.060 |
Why?
|
| Hepacivirus | 1 | 2006 | 397 | 0.060 |
Why?
|
| Chimera | 2 | 2014 | 145 | 0.050 |
Why?
|
| Liver Failure, Acute | 1 | 2004 | 88 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 3 | 2016 | 64 | 0.050 |
Why?
|
| Liver Function Tests | 3 | 2017 | 173 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2009 | 1085 | 0.050 |
Why?
|
| Glucose | 1 | 2008 | 1248 | 0.050 |
Why?
|
| Hydroxysteroid Dehydrogenases | 2 | 1972 | 19 | 0.050 |
Why?
|
| Interleukin-12 | 2 | 2010 | 253 | 0.050 |
Why?
|
| Haplorhini | 4 | 1997 | 130 | 0.050 |
Why?
|
| Adult | 22 | 2023 | 77950 | 0.050 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2005 | 366 | 0.050 |
Why?
|
| Keratins | 1 | 2003 | 330 | 0.050 |
Why?
|
| Response Elements | 2 | 2015 | 193 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 6 | 2011 | 2314 | 0.050 |
Why?
|
| Ovarian Neoplasms | 6 | 1996 | 4638 | 0.050 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2002 | 51 | 0.050 |
Why?
|
| Cyclin E | 1 | 2004 | 267 | 0.050 |
Why?
|
| Respiratory Mucosa | 1 | 2003 | 206 | 0.050 |
Why?
|
| Species Specificity | 5 | 2012 | 777 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2004 | 414 | 0.050 |
Why?
|
| Copper-transporting ATPases | 2 | 2015 | 44 | 0.050 |
Why?
|
| Organ Size | 4 | 2018 | 690 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2019 | 2218 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 669 | 0.050 |
Why?
|
| Respiratory Therapy | 1 | 1981 | 30 | 0.050 |
Why?
|
| Colony-Forming Units Assay | 2 | 2017 | 249 | 0.050 |
Why?
|
| Lung Neoplasms | 5 | 2017 | 11538 | 0.050 |
Why?
|
| Intubation | 1 | 1981 | 40 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 1998 | 311 | 0.050 |
Why?
|
| Neoplasm Metastasis | 5 | 2002 | 5112 | 0.050 |
Why?
|
| Starch | 1 | 1981 | 47 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2006 | 1450 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2013 | 171 | 0.050 |
Why?
|
| Antineoplastic Agents | 5 | 2020 | 14289 | 0.050 |
Why?
|
| Skull Neoplasms | 1 | 2001 | 67 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 8 | 2010 | 5395 | 0.050 |
Why?
|
| Antibodies, Viral | 5 | 1999 | 1320 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2011 | 252 | 0.050 |
Why?
|
| Crosses, Genetic | 4 | 2004 | 241 | 0.050 |
Why?
|
| Chromosomes, Mammalian | 2 | 2012 | 59 | 0.050 |
Why?
|
| Europe | 1 | 2002 | 649 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 4 | 1996 | 1555 | 0.050 |
Why?
|
| Hepatitis B Antigens | 1 | 2000 | 15 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 4988 | 0.050 |
Why?
|
| Kidney Tubules | 2 | 1971 | 137 | 0.050 |
Why?
|
| Smad3 Protein | 2 | 2016 | 129 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 5 | 1998 | 132 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2003 | 837 | 0.050 |
Why?
|
| Nucleoside Deaminases | 1 | 2000 | 33 | 0.050 |
Why?
|
| Biopsy, Needle | 2 | 2016 | 1363 | 0.050 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2005 | 489 | 0.050 |
Why?
|
| X Chromosome | 2 | 1999 | 339 | 0.050 |
Why?
|
| Prostatic Neoplasms | 4 | 2000 | 5767 | 0.050 |
Why?
|
| Lymphoma, T-Cell | 1 | 2003 | 361 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2005 | 1090 | 0.050 |
Why?
|
| Cloning, Molecular | 7 | 1999 | 1213 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2003 | 448 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 2054 | 0.050 |
Why?
|
| Ki-1 Antigen | 1 | 2001 | 182 | 0.050 |
Why?
|
| Dogs | 8 | 1994 | 1155 | 0.050 |
Why?
|
| Monocytes | 1 | 2004 | 788 | 0.050 |
Why?
|
| Craniocerebral Trauma | 1 | 2001 | 130 | 0.050 |
Why?
|
| Osteosarcoma | 2 | 1997 | 929 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2019 | 741 | 0.050 |
Why?
|
| Toxicity Tests | 1 | 2020 | 50 | 0.040 |
Why?
|
| Survival Rate | 5 | 2020 | 12221 | 0.040 |
Why?
|
| DNA Mutational Analysis | 3 | 2014 | 2283 | 0.040 |
Why?
|
| Suppression, Genetic | 1 | 1999 | 67 | 0.040 |
Why?
|
| Rats, Inbred F344 | 2 | 1998 | 224 | 0.040 |
Why?
|
| Medical Oncology | 1 | 2008 | 1423 | 0.040 |
Why?
|
| Jagged-1 Protein | 1 | 2020 | 101 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2012 | 490 | 0.040 |
Why?
|
| Herpesvirus 6, Human | 1 | 2000 | 81 | 0.040 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2019 | 6 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 257 | 0.040 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1999 | 7 | 0.040 |
Why?
|
| Feasibility Studies | 3 | 2021 | 2292 | 0.040 |
Why?
|
| Infant, Premature | 2 | 1982 | 787 | 0.040 |
Why?
|
| IgA Deficiency | 1 | 1999 | 6 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 222 | 0.040 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1999 | 36 | 0.040 |
Why?
|
| Ileum | 2 | 1995 | 165 | 0.040 |
Why?
|
| Diet | 2 | 2005 | 1440 | 0.040 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2020 | 80 | 0.040 |
Why?
|
| Myogenin | 1 | 1999 | 33 | 0.040 |
Why?
|
| Francisella tularensis | 2 | 1969 | 19 | 0.040 |
Why?
|
| Autopsy | 7 | 1975 | 173 | 0.040 |
Why?
|
| Hepatic Veins | 1 | 1999 | 58 | 0.040 |
Why?
|
| Prostatic Hyperplasia | 1 | 2000 | 210 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 1999 | 119 | 0.040 |
Why?
|
| Osteoblasts | 2 | 2009 | 370 | 0.040 |
Why?
|
| Sex Factors | 4 | 2005 | 2139 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2020 | 112 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2011 | 2508 | 0.040 |
Why?
|
| Ataxia Telangiectasia | 1 | 1999 | 62 | 0.040 |
Why?
|
| Capsid Proteins | 2 | 2016 | 185 | 0.040 |
Why?
|
| Myxoma | 1 | 1979 | 63 | 0.040 |
Why?
|
| Telomere Homeostasis | 1 | 2019 | 73 | 0.040 |
Why?
|
| Heart Neoplasms | 2 | 1979 | 214 | 0.040 |
Why?
|
| Cell Transformation, Viral | 2 | 1997 | 138 | 0.040 |
Why?
|
| Abnormal Karyotype | 1 | 2018 | 100 | 0.040 |
Why?
|
| Hepatitis B, Chronic | 1 | 2000 | 137 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2018 | 22 | 0.040 |
Why?
|
| Combined Modality Therapy | 6 | 2016 | 8865 | 0.040 |
Why?
|
| Genes, myc | 1 | 2000 | 358 | 0.040 |
Why?
|
| T-Lymphocytes | 3 | 2003 | 3869 | 0.040 |
Why?
|
| Rats, Inbred Lew | 3 | 2006 | 113 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 89 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 2216 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2019 | 165 | 0.040 |
Why?
|
| Stillbirth | 1 | 2019 | 82 | 0.040 |
Why?
|
| Perinatal Care | 1 | 2019 | 63 | 0.040 |
Why?
|
| Endocardial Fibroelastosis | 1 | 1978 | 12 | 0.040 |
Why?
|
| Precancerous Conditions | 3 | 2001 | 1058 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1999 | 182 | 0.040 |
Why?
|
| Oncogenes | 2 | 2018 | 673 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2012 | 691 | 0.040 |
Why?
|
| Sheep | 3 | 1993 | 258 | 0.040 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1998 | 222 | 0.040 |
Why?
|
| Transplantation, Homologous | 3 | 2019 | 2843 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2019 | 348 | 0.040 |
Why?
|
| North America | 1 | 2018 | 314 | 0.040 |
Why?
|
| Homozygote | 4 | 2006 | 717 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1998 | 129 | 0.040 |
Why?
|
| Acyltransferases | 1 | 2018 | 62 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 1999 | 161 | 0.040 |
Why?
|
| Transplantation, Autologous | 5 | 2006 | 1914 | 0.040 |
Why?
|
| Amino Acid Sequence | 5 | 2012 | 4233 | 0.040 |
Why?
|
| Androgen-Binding Protein | 2 | 1995 | 39 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2016 | 1863 | 0.040 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 162 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 292 | 0.040 |
Why?
|
| Gait | 2 | 1998 | 165 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6207 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 3 | 2004 | 205 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 1999 | 512 | 0.040 |
Why?
|
| Rituximab | 2 | 2017 | 1528 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 1998 | 129 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2000 | 482 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1997 | 108 | 0.040 |
Why?
|
| Energy Metabolism | 2 | 2011 | 992 | 0.040 |
Why?
|
| Mice, Congenic | 2 | 2010 | 30 | 0.040 |
Why?
|
| Hepatitis B | 2 | 1994 | 258 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 1998 | 149 | 0.040 |
Why?
|
| Barium | 1 | 1997 | 26 | 0.040 |
Why?
|
| Muscle, Skeletal | 3 | 1999 | 1270 | 0.040 |
Why?
|
| DNA Helicases | 1 | 1999 | 434 | 0.040 |
Why?
|
| Lymphotoxin-beta | 1 | 2016 | 3 | 0.040 |
Why?
|
| Genome, Human | 2 | 2020 | 1869 | 0.040 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1996 | 40 | 0.040 |
Why?
|
| Lipofuscin | 1 | 2016 | 3 | 0.040 |
Why?
|
| Cell Line, Transformed | 3 | 2003 | 394 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2018 | 241 | 0.040 |
Why?
|
| Neutrophils | 1 | 2001 | 835 | 0.040 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2001 | 387 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 650 | 0.040 |
Why?
|
| Kidney Transplantation | 2 | 1999 | 755 | 0.040 |
Why?
|
| Pigmentation | 1 | 2016 | 47 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 1996 | 86 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2021 | 12873 | 0.040 |
Why?
|
| DNA, Complementary | 3 | 2004 | 869 | 0.040 |
Why?
|
| Mitochondria | 3 | 1978 | 1282 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 418 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 1493 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2016 | 1519 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 905 | 0.040 |
Why?
|
| Germinoma | 1 | 1996 | 84 | 0.040 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 984 | 0.040 |
Why?
|
| Genes, bcl-2 | 1 | 1996 | 166 | 0.030 |
Why?
|
| CCCTC-Binding Factor | 1 | 2016 | 33 | 0.030 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2016 | 20 | 0.030 |
Why?
|
| Inflammation | 2 | 2023 | 2522 | 0.030 |
Why?
|
| Transcriptome | 2 | 2017 | 1859 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 2 | 2009 | 49 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 1996 | 78 | 0.030 |
Why?
|
| Organ Specificity | 4 | 2006 | 699 | 0.030 |
Why?
|
| Molecular Biology | 2 | 1994 | 176 | 0.030 |
Why?
|
| Genetic Markers | 3 | 1999 | 974 | 0.030 |
Why?
|
| Heptanoates | 1 | 1995 | 2 | 0.030 |
Why?
|
| Vision Disorders | 1 | 1998 | 245 | 0.030 |
Why?
|
| Genes, Reporter | 4 | 2004 | 798 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 14889 | 0.030 |
Why?
|
| Receptors, Growth Factor | 1 | 1996 | 157 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 409 | 0.030 |
Why?
|
| Ovarian Follicle | 1 | 1996 | 152 | 0.030 |
Why?
|
| Infliximab | 1 | 2016 | 130 | 0.030 |
Why?
|
| Prevalence | 2 | 2019 | 3260 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 1999 | 384 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 2 | 1999 | 589 | 0.030 |
Why?
|
| Kidney Medulla | 3 | 1997 | 43 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 108 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 149 | 0.030 |
Why?
|
| Skin | 3 | 1999 | 1259 | 0.030 |
Why?
|
| Homeodomain Proteins | 3 | 2009 | 1143 | 0.030 |
Why?
|
| RNA, Untranslated | 2 | 2010 | 237 | 0.030 |
Why?
|
| Fasting | 3 | 2008 | 349 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 829 | 0.030 |
Why?
|
| Microscopy | 1 | 2016 | 182 | 0.030 |
Why?
|
| Intestinal Neoplasms | 1 | 1977 | 189 | 0.030 |
Why?
|
| Neoplasms, Experimental | 2 | 1996 | 750 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2015 | 3552 | 0.030 |
Why?
|
| Y Chromosome | 1 | 1995 | 77 | 0.030 |
Why?
|
| Genitalia, Male | 1 | 1994 | 36 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 408 | 0.030 |
Why?
|
| Carcinogens | 1 | 1996 | 384 | 0.030 |
Why?
|
| Artificial Organs | 1 | 1994 | 5 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2010 | 842 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2014 | 41 | 0.030 |
Why?
|
| Dysautonomia, Familial | 2 | 1971 | 2 | 0.030 |
Why?
|
| Mice, Nude | 3 | 2016 | 4307 | 0.030 |
Why?
|
| Choline Deficiency | 1 | 2014 | 10 | 0.030 |
Why?
|
| Esterification | 1 | 1994 | 16 | 0.030 |
Why?
|
| CD8 Antigens | 2 | 2006 | 170 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 3 | 1993 | 308 | 0.030 |
Why?
|
| Cholesterol Esters | 1 | 1994 | 34 | 0.030 |
Why?
|
| Bone Neoplasms | 2 | 1997 | 2576 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 3472 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 1994 | 21 | 0.030 |
Why?
|
| Pilocarpine | 1 | 1994 | 21 | 0.030 |
Why?
|
| Homeostasis | 2 | 2016 | 950 | 0.030 |
Why?
|
| Umbilical Arteries | 1 | 1974 | 59 | 0.030 |
Why?
|
| Expectorants | 1 | 1994 | 13 | 0.030 |
Why?
|
| Extracorporeal Circulation | 1 | 1994 | 43 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 2 | 2005 | 5061 | 0.030 |
Why?
|
| Enteroendocrine Cells | 2 | 2006 | 24 | 0.030 |
Why?
|
| United States | 3 | 2019 | 15433 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 2 | 2005 | 41 | 0.030 |
Why?
|
| Enzyme Induction | 2 | 2010 | 249 | 0.030 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 1994 | 49 | 0.030 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2015 | 59 | 0.030 |
Why?
|
| Albinism | 1 | 1993 | 17 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2005 | 2638 | 0.030 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2013 | 13 | 0.030 |
Why?
|
| Vomiting | 1 | 2016 | 354 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 1977 | 335 | 0.030 |
Why?
|
| CD3 Complex | 2 | 2006 | 314 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2016 | 402 | 0.030 |
Why?
|
| Los Angeles | 1 | 2013 | 31 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 1997 | 487 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 1029 | 0.030 |
Why?
|
| Mullerian Ducts | 1 | 1994 | 76 | 0.030 |
Why?
|
| Genetic Complementation Test | 2 | 2005 | 125 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 1996 | 187 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 525 | 0.030 |
Why?
|
| DNA, Neoplasm | 3 | 2001 | 1910 | 0.030 |
Why?
|
| Metabolome | 1 | 2016 | 344 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1996 | 429 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 342 | 0.030 |
Why?
|
| Glycosaminoglycans | 2 | 1973 | 61 | 0.030 |
Why?
|
| DNA Replication | 2 | 2013 | 744 | 0.030 |
Why?
|
| Mitosis | 2 | 2010 | 615 | 0.030 |
Why?
|
| DNA Repair | 4 | 2003 | 1872 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 571 | 0.030 |
Why?
|
| Granuloma | 1 | 1995 | 154 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 3438 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1995 | 224 | 0.030 |
Why?
|
| Thrombospondins | 1 | 2013 | 21 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2004 | 166 | 0.030 |
Why?
|
| Genes, Synthetic | 1 | 1992 | 26 | 0.030 |
Why?
|
| Histone Deacetylase 1 | 1 | 2013 | 62 | 0.030 |
Why?
|
| Time | 1 | 2013 | 178 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 1994 | 143 | 0.030 |
Why?
|
| Mosaicism | 1 | 2015 | 272 | 0.030 |
Why?
|
| Osteocalcin | 1 | 1993 | 87 | 0.030 |
Why?
|
| Gonads | 1 | 1992 | 53 | 0.030 |
Why?
|
| Hypopigmentation | 1 | 2012 | 28 | 0.030 |
Why?
|
| Binding Sites | 2 | 2010 | 2171 | 0.030 |
Why?
|
| Androstanes | 1 | 1972 | 2 | 0.030 |
Why?
|
| Hirschsprung Disease | 1 | 2012 | 46 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2015 | 382 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 1975 | 245 | 0.030 |
Why?
|
| Ovary | 1 | 1996 | 668 | 0.030 |
Why?
|
| Ganglia, Autonomic | 2 | 1971 | 4 | 0.030 |
Why?
|
| Cell Nucleus | 3 | 2006 | 1620 | 0.030 |
Why?
|
| Butyrates | 1 | 2012 | 57 | 0.030 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2014 | 193 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2016 | 383 | 0.030 |
Why?
|
| Obesity | 1 | 2005 | 2884 | 0.030 |
Why?
|
| Premedication | 1 | 1992 | 135 | 0.030 |
Why?
|
| Endotoxins | 3 | 2005 | 96 | 0.030 |
Why?
|
| Prostate | 2 | 1997 | 1088 | 0.030 |
Why?
|
| Kinetics | 2 | 2012 | 2049 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2018 | 899 | 0.030 |
Why?
|
| Ganciclovir | 3 | 1997 | 174 | 0.030 |
Why?
|
| Organophosphorus Compounds | 1 | 2012 | 101 | 0.030 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 1992 | 26 | 0.030 |
Why?
|
| Culture Media | 1 | 2013 | 319 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 170 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 5539 | 0.030 |
Why?
|
| Amino Acids | 1 | 1995 | 728 | 0.030 |
Why?
|
| Patched Receptors | 1 | 2011 | 46 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2017 | 1152 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2012 | 72 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 2017 | 831 | 0.030 |
Why?
|
| Thinness | 1 | 2012 | 82 | 0.030 |
Why?
|
| Karyotype | 1 | 2012 | 234 | 0.030 |
Why?
|
| Uterus | 1 | 1997 | 678 | 0.030 |
Why?
|
| Patched-1 Receptor | 1 | 2011 | 48 | 0.030 |
Why?
|
| Jaundice, Neonatal | 2 | 1985 | 12 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2009 | 622 | 0.030 |
Why?
|
| Ataxins | 1 | 2011 | 91 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2012 | 122 | 0.030 |
Why?
|
| Glucans | 1 | 2011 | 18 | 0.030 |
Why?
|
| DiGeorge Syndrome | 1 | 1992 | 77 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 1586 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 1997 | 1245 | 0.030 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1992 | 107 | 0.030 |
Why?
|
| Glycogen | 1 | 2011 | 80 | 0.030 |
Why?
|
| Rodent Diseases | 1 | 2011 | 29 | 0.030 |
Why?
|
| Cholesterol Ester Storage Disease | 1 | 1991 | 3 | 0.030 |
Why?
|
| Heart Diseases | 1 | 1978 | 732 | 0.030 |
Why?
|
| Influenza B virus | 1 | 1992 | 127 | 0.030 |
Why?
|
| Oxygen | 2 | 2008 | 754 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 2265 | 0.020 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2010 | 6 | 0.020 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2010 | 6 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 392 | 0.020 |
Why?
|
| Diarrhea, Infantile | 2 | 1992 | 43 | 0.020 |
Why?
|
| Spinal Nerves | 1 | 1971 | 45 | 0.020 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2010 | 34 | 0.020 |
Why?
|
| Ataxin-1 | 1 | 2011 | 148 | 0.020 |
Why?
|
| Organogenesis | 1 | 2011 | 119 | 0.020 |
Why?
|
| Cyclin D2 | 1 | 2010 | 40 | 0.020 |
Why?
|
| Ligation | 2 | 2006 | 193 | 0.020 |
Why?
|
| Peristalsis | 1 | 2010 | 7 | 0.020 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 550 | 0.020 |
Why?
|
| Vitamin D | 1 | 1993 | 261 | 0.020 |
Why?
|
| Genes, Viral | 3 | 1997 | 202 | 0.020 |
Why?
|
| India | 1 | 1991 | 301 | 0.020 |
Why?
|
| Malabsorption Syndromes | 1 | 2011 | 55 | 0.020 |
Why?
|
| Pulmonary Edema | 2 | 1969 | 80 | 0.020 |
Why?
|
| Hospitalization | 1 | 1999 | 2083 | 0.020 |
Why?
|
| Spindle Apparatus | 1 | 2010 | 93 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2006 | 2063 | 0.020 |
Why?
|
| Oncogene Proteins | 3 | 2000 | 354 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 703 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2010 | 82 | 0.020 |
Why?
|
| Genotype | 2 | 2014 | 4109 | 0.020 |
Why?
|
| Bortezomib | 1 | 2012 | 543 | 0.020 |
Why?
|
| Homologous Recombination | 1 | 2011 | 185 | 0.020 |
Why?
|
| SMARCB1 Protein | 1 | 2010 | 109 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2012 | 362 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 518 | 0.020 |
Why?
|
| Epithelial Cell Adhesion Molecule | 1 | 2010 | 35 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 360 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 4314 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2011 | 211 | 0.020 |
Why?
|
| Thorax | 1 | 1971 | 213 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2019 | 1225 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 423 | 0.020 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2011 | 204 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 1764 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 826 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 4938 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2010 | 153 | 0.020 |
Why?
|
| Heart Defects, Congenital | 4 | 1975 | 1697 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1992 | 362 | 0.020 |
Why?
|
| Genome | 1 | 2013 | 672 | 0.020 |
Why?
|
| Ependymoma | 1 | 1992 | 242 | 0.020 |
Why?
|
| Gastroenteritis | 1 | 2012 | 300 | 0.020 |
Why?
|
| Pasteurella Infections | 1 | 1969 | 9 | 0.020 |
Why?
|
| Cadaver | 1 | 2010 | 237 | 0.020 |
Why?
|
| Systems Biology | 1 | 2010 | 112 | 0.020 |
Why?
|
| Adrenal Gland Diseases | 1 | 1970 | 72 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 558 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2010 | 236 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 542 | 0.020 |
Why?
|
| Fatigue | 1 | 2016 | 1239 | 0.020 |
Why?
|
| Activin Receptors | 2 | 2001 | 19 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2010 | 229 | 0.020 |
Why?
|
| Cytokinins | 1 | 1989 | 3 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 3441 | 0.020 |
Why?
|
| Pyrazines | 1 | 2012 | 495 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2009 | 84 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2009 | 29 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2011 | 148 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2002 | 93 | 0.020 |
Why?
|
| Antibodies | 1 | 2012 | 838 | 0.020 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2008 | 95 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 611 | 0.020 |
Why?
|
| Spine | 5 | 1999 | 293 | 0.020 |
Why?
|
| Epigenomics | 1 | 2010 | 266 | 0.020 |
Why?
|
| Restriction Mapping | 2 | 2004 | 264 | 0.020 |
Why?
|
| Transplantation | 1 | 1989 | 56 | 0.020 |
Why?
|
| Oocytes | 1 | 2011 | 414 | 0.020 |
Why?
|
| Serine | 1 | 2010 | 388 | 0.020 |
Why?
|
| Overweight | 1 | 2012 | 484 | 0.020 |
Why?
|
| Immunity, Cellular | 2 | 2005 | 419 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 506 | 0.020 |
Why?
|
| Inactivation, Metabolic | 1 | 2008 | 37 | 0.020 |
Why?
|
| Genes | 1 | 1989 | 491 | 0.020 |
Why?
|
| Mite Infestations | 1 | 1968 | 5 | 0.020 |
Why?
|
| Mammals | 1 | 2010 | 361 | 0.020 |
Why?
|
| Virulence | 1 | 1969 | 323 | 0.020 |
Why?
|
| Lung Diseases, Parasitic | 1 | 1968 | 14 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 644 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2010 | 344 | 0.020 |
Why?
|
| Toxins, Biological | 1 | 1968 | 51 | 0.020 |
Why?
|
| Spin Labels | 1 | 2008 | 76 | 0.020 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2008 | 61 | 0.020 |
Why?
|
| Bile Canaliculi | 1 | 1987 | 6 | 0.020 |
Why?
|
| Monkey Diseases | 1 | 1968 | 50 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2010 | 362 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 2005 | 684 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2015 | 9244 | 0.020 |
Why?
|
| Oleanolic Acid | 1 | 2008 | 108 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 1971 | 330 | 0.020 |
Why?
|
| Tolazamide | 1 | 1987 | 1 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2007 | 2315 | 0.020 |
Why?
|
| Etoposide | 2 | 2002 | 870 | 0.020 |
Why?
|
| Myotonic Dystrophy | 1 | 1969 | 151 | 0.020 |
Why?
|
| Nitriles | 1 | 1972 | 906 | 0.020 |
Why?
|
| Weight Loss | 2 | 2006 | 627 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2010 | 351 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2007 | 196 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3821 | 0.020 |
Why?
|
| Virus Replication | 3 | 1997 | 709 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2008 | 365 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1360 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1987 | 55 | 0.020 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1971 | 300 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 6100 | 0.020 |
Why?
|
| Phosphates | 1 | 1968 | 187 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 630 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2009 | 291 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1992 | 830 | 0.020 |
Why?
|
| Enterotoxins | 1 | 1967 | 112 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 595 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 266 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2010 | 353 | 0.020 |
Why?
|
| Mice, Inbred ICR | 2 | 2000 | 239 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 1968 | 120 | 0.020 |
Why?
|
| Serum Albumin | 2 | 1999 | 257 | 0.020 |
Why?
|
| Avian Sarcoma Viruses | 2 | 1997 | 41 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1070 | 0.020 |
Why?
|
| Glutathione Disulfide | 1 | 2006 | 20 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 2 | 1996 | 197 | 0.020 |
Why?
|
| Venae Cavae | 1 | 2006 | 11 | 0.020 |
Why?
|
| Craniofacial Dysostosis | 2 | 1976 | 9 | 0.020 |
Why?
|
| Ligands | 2 | 2001 | 995 | 0.020 |
Why?
|
| Glucagon-Like Peptide-2 Receptor | 1 | 2006 | 15 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 545 | 0.020 |
Why?
|
| Ceruloplasmin | 1 | 2006 | 35 | 0.020 |
Why?
|
| Weight Gain | 1 | 2009 | 464 | 0.020 |
Why?
|
| Infusions, Intravenous | 2 | 2003 | 1382 | 0.020 |
Why?
|
| Motor Neurons, Gamma | 1 | 1985 | 1 | 0.020 |
Why?
|
| Thrombosis | 3 | 1975 | 781 | 0.020 |
Why?
|
| Neurons, Efferent | 1 | 1985 | 6 | 0.020 |
Why?
|
| Muscle Tonus | 1 | 1985 | 13 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2004 | 6550 | 0.020 |
Why?
|
| Triglycerides | 1 | 2008 | 603 | 0.020 |
Why?
|
| Biliary Tract Diseases | 1 | 1986 | 61 | 0.020 |
Why?
|
| Leydig Cells | 2 | 1996 | 39 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 803 | 0.020 |
Why?
|
| Pneumonia | 2 | 1969 | 751 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2006 | 55 | 0.020 |
Why?
|
| Salivary Glands, Minor | 1 | 2005 | 33 | 0.020 |
Why?
|
| Embryology | 1 | 1965 | 3 | 0.020 |
Why?
|
| Genomics | 1 | 2016 | 2738 | 0.020 |
Why?
|
| Orchiectomy | 2 | 1997 | 214 | 0.020 |
Why?
|
| Aortic Arch Syndromes | 1 | 1965 | 11 | 0.020 |
Why?
|
| In Vitro Techniques | 3 | 1997 | 1618 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2006 | 145 | 0.020 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1985 | 13 | 0.020 |
Why?
|
| Transaminases | 1 | 2005 | 76 | 0.020 |
Why?
|
| Rats, Gunn | 1 | 2005 | 5 | 0.020 |
Why?
|
| Cytosol | 1 | 2006 | 238 | 0.020 |
Why?
|
| Truncus Arteriosus | 1 | 1965 | 14 | 0.020 |
Why?
|
| Morphogenesis | 2 | 1999 | 337 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 650 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1516 | 0.020 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2005 | 29 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2006 | 331 | 0.020 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 1965 | 16 | 0.020 |
Why?
|
| Thymidine | 1 | 1965 | 155 | 0.020 |
Why?
|
| Disorders of Sex Development | 2 | 1996 | 88 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1987 | 305 | 0.020 |
Why?
|
| Antiviral Agents | 2 | 2006 | 1230 | 0.020 |
Why?
|
| Endotoxemia | 1 | 2005 | 61 | 0.020 |
Why?
|
| Metabolism | 1 | 1965 | 55 | 0.020 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1986 | 125 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 157 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1985 | 245 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 942 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 276 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2005 | 89 | 0.020 |
Why?
|
| Middle Aged | 4 | 2023 | 86204 | 0.020 |
Why?
|
| Kidney Glomerulus | 3 | 1971 | 156 | 0.020 |
Why?
|
| Bundle of His | 1 | 1984 | 9 | 0.020 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2004 | 22 | 0.020 |
Why?
|
| Hepatic Artery | 1 | 2006 | 240 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1985 | 295 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 265 | 0.020 |
Why?
|
| Nervous System | 1 | 1985 | 165 | 0.020 |
Why?
|
| Testis | 2 | 2002 | 717 | 0.020 |
Why?
|
| Acute Disease | 2 | 2005 | 2422 | 0.020 |
Why?
|
| Anti-Mullerian Hormone | 2 | 1995 | 61 | 0.020 |
Why?
|
| Heart Block | 1 | 1984 | 48 | 0.020 |
Why?
|
| Genetic Carrier Screening | 1 | 2005 | 92 | 0.020 |
Why?
|
| Epidermis | 1 | 1965 | 188 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2009 | 677 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2010 | 731 | 0.020 |
Why?
|
| Viral Load | 1 | 2006 | 493 | 0.020 |
Why?
|
| Receptor, Notch4 | 1 | 2004 | 13 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 2307 | 0.020 |
Why?
|
| Safety | 1 | 2006 | 465 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 1998 | 682 | 0.020 |
Why?
|
| Influenza, Human | 1 | 1992 | 925 | 0.020 |
Why?
|
| Capillaries | 3 | 1969 | 99 | 0.020 |
Why?
|
| Bacteriophages | 1 | 2005 | 71 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2006 | 234 | 0.020 |
Why?
|
| Galactosides | 1 | 2004 | 26 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2005 | 562 | 0.020 |
Why?
|
| Central Nervous System Depressants | 1 | 2004 | 26 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 1408 | 0.020 |
Why?
|
| Azacitidine | 1 | 2010 | 1149 | 0.020 |
Why?
|
| Aged | 2 | 2023 | 70117 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1965 | 173 | 0.010 |
Why?
|
| Albumins | 2 | 1998 | 258 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2003 | 33 | 0.010 |
Why?
|
| 5' Flanking Region | 1 | 2003 | 21 | 0.010 |
Why?
|
| Dicarbethoxydihydrocollidine | 1 | 2003 | 4 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 6009 | 0.010 |
Why?
|
| Placentation | 1 | 2004 | 60 | 0.010 |
Why?
|
| Urothelium | 1 | 2005 | 254 | 0.010 |
Why?
|
| Leukocyte Common Antigens | 1 | 2004 | 188 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 1992 | 715 | 0.010 |
Why?
|
| Portal Vein | 1 | 2006 | 355 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 150 | 0.010 |
Why?
|
| Leukocytes | 1 | 1985 | 422 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 1984 | 165 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 161 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2003 | 170 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 661 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 173 | 0.010 |
Why?
|
| Wound Healing | 2 | 1985 | 815 | 0.010 |
Why?
|
| Diploidy | 1 | 2003 | 114 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2006 | 749 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2005 | 403 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 844 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2008 | 2231 | 0.010 |
Why?
|
| Fertility | 2 | 1996 | 336 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1985 | 238 | 0.010 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2002 | 3 | 0.010 |
Why?
|
| Acetaminophen | 1 | 2004 | 116 | 0.010 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 1 | 2002 | 7 | 0.010 |
Why?
|
| Cryosurgery | 1 | 1984 | 167 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2005 | 446 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2006 | 576 | 0.010 |
Why?
|
| Cell Count | 2 | 1996 | 508 | 0.010 |
Why?
|
| Imidazoles | 1 | 2008 | 999 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1986 | 615 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 2291 | 0.010 |
Why?
|
| Kanamycin Kinase | 2 | 1993 | 18 | 0.010 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2002 | 40 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2004 | 218 | 0.010 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2004 | 126 | 0.010 |
Why?
|
| Research | 1 | 1965 | 415 | 0.010 |
Why?
|
| Mandibulofacial Dysostosis | 3 | 1976 | 16 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2003 | 271 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2005 | 864 | 0.010 |
Why?
|
| Electron Transport Complex IV | 2 | 1972 | 57 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2001 | 53 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1983 | 108 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 2 | 1972 | 64 | 0.010 |
Why?
|
| Seizures | 1 | 2008 | 989 | 0.010 |
Why?
|
| Phosphotransferases | 2 | 1993 | 84 | 0.010 |
Why?
|
| Intestine, Large | 1 | 2001 | 28 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 293 | 0.010 |
Why?
|
| Vacuoles | 1 | 2002 | 51 | 0.010 |
Why?
|
| Paneth Cells | 1 | 2001 | 23 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 153 | 0.010 |
Why?
|
| Ethanol | 1 | 2004 | 264 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2003 | 726 | 0.010 |
Why?
|
| Stents | 1 | 2008 | 1096 | 0.010 |
Why?
|
| E2F6 Transcription Factor | 1 | 2001 | 8 | 0.010 |
Why?
|
| Mitochondrial Swelling | 2 | 1972 | 10 | 0.010 |
Why?
|
| Ketosteroids | 2 | 1972 | 6 | 0.010 |
Why?
|
| Common Bile Duct | 2 | 1987 | 27 | 0.010 |
Why?
|
| Fibroblast Growth Factor 3 | 1 | 2001 | 22 | 0.010 |
Why?
|
| Glucagon | 2 | 1995 | 196 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2006 | 1038 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1997 | 5437 | 0.010 |
Why?
|
| Registries | 2 | 2005 | 2170 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2002 | 242 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 652 | 0.010 |
Why?
|
| BRCA2 Protein | 1 | 2003 | 358 | 0.010 |
Why?
|
| B-Lymphocytes | 2 | 2003 | 1294 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2003 | 575 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 329 | 0.010 |
Why?
|
| Mifepristone | 1 | 2001 | 147 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2006 | 846 | 0.010 |
Why?
|
| Risk | 1 | 1985 | 1972 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2005 | 783 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 1225 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 1999 | 2483 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2002 | 587 | 0.010 |
Why?
|
| Blood Glucose | 2 | 1995 | 1244 | 0.010 |
Why?
|
| Goblet Cells | 1 | 2001 | 135 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2002 | 318 | 0.010 |
Why?
|
| Chaperonins | 1 | 2000 | 27 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2001 | 195 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1961 | 339 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 2000 | 73 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2001 | 185 | 0.010 |
Why?
|
| Skull | 2 | 1993 | 231 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2001 | 240 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 2 | 1997 | 3981 | 0.010 |
Why?
|
| Cytosine Deaminase | 1 | 2000 | 39 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2009 | 2295 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 1993 | 769 | 0.010 |
Why?
|
| Pancreatic Ducts | 1 | 2001 | 122 | 0.010 |
Why?
|
| Acetoacetates | 1 | 1999 | 20 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1965 | 546 | 0.010 |
Why?
|
| Ethylnitrosourea | 1 | 1999 | 19 | 0.010 |
Why?
|
| Gene Conversion | 1 | 1999 | 19 | 0.010 |
Why?
|
| Epiphyses | 1 | 1999 | 13 | 0.010 |
Why?
|
| Polyomavirus | 1 | 1999 | 30 | 0.010 |
Why?
|
| Heart Ventricles | 2 | 1978 | 846 | 0.010 |
Why?
|
| Methods | 3 | 1986 | 189 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 2000 | 307 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2001 | 666 | 0.010 |
Why?
|
| Ku Autoantigen | 1 | 1999 | 79 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2001 | 252 | 0.010 |
Why?
|
| Clinical Protocols | 2 | 1993 | 467 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 1999 | 17 | 0.010 |
Why?
|
| Cardiomegaly | 2 | 1978 | 195 | 0.010 |
Why?
|
| Cortisone | 2 | 1969 | 18 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2002 | 875 | 0.010 |
Why?
|
| Yersinia pestis | 2 | 1969 | 11 | 0.010 |
Why?
|
| Pharynx | 1 | 1999 | 153 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 1073 | 0.010 |
Why?
|
| Melanoma | 1 | 1996 | 5317 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 2002 | 629 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1999 | 95 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1961 | 482 | 0.010 |
Why?
|
| Bone Development | 1 | 1999 | 83 | 0.010 |
Why?
|
| Electrocardiography | 3 | 1984 | 1145 | 0.010 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1998 | 47 | 0.010 |
Why?
|
| Tyrosine Transaminase | 1 | 1998 | 14 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1987 | 1054 | 0.010 |
Why?
|
| Respiratory Tract Diseases | 1 | 1999 | 111 | 0.010 |
Why?
|
| Ascites | 1 | 1999 | 198 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1999 | 284 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1999 | 237 | 0.010 |
Why?
|
| Feces | 1 | 2002 | 770 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1998 | 227 | 0.010 |
Why?
|
| Protein Biosynthesis | 2 | 1993 | 889 | 0.010 |
Why?
|
| Indoles | 1 | 2004 | 1009 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1998 | 139 | 0.010 |
Why?
|
| Graft Survival | 2 | 1992 | 1062 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1978 | 78 | 0.010 |
Why?
|
| Recurrence | 1 | 2006 | 4758 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1997 | 71 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 1999 | 602 | 0.010 |
Why?
|
| Defective Viruses | 1 | 1997 | 28 | 0.010 |
Why?
|
| Lymphatic Metastasis | 2 | 1997 | 4844 | 0.010 |
Why?
|
| Seminal Vesicles | 1 | 1997 | 152 | 0.010 |
Why?
|
| Rubella virus | 1 | 1977 | 10 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1999 | 242 | 0.010 |
Why?
|
| Adrenal Cortex | 1 | 1997 | 35 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1999 | 233 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1969 | 573 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 2006 | 1429 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2005 | 2203 | 0.010 |
Why?
|
| Rubella | 1 | 1977 | 22 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1997 | 256 | 0.010 |
Why?
|
| Capsid | 1 | 1997 | 103 | 0.010 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1977 | 36 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1997 | 191 | 0.010 |
Why?
|
| Gonadotropins, Equine | 1 | 1996 | 12 | 0.010 |
Why?
|
| Litter Size | 1 | 1996 | 26 | 0.010 |
Why?
|
| Cyclophosphamide | 2 | 1997 | 3001 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1997 | 88 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2003 | 1146 | 0.010 |
Why?
|
| Antigens | 1 | 1978 | 292 | 0.010 |
Why?
|
| Hernia, Umbilical | 1 | 1997 | 36 | 0.010 |
Why?
|
| Carcinogenicity Tests | 1 | 1996 | 70 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1997 | 145 | 0.010 |
Why?
|
| Paraffin Embedding | 1 | 1997 | 226 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1996 | 57 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 1549 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1998 | 249 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 2594 | 0.010 |
Why?
|
| Seminiferous Tubules | 1 | 1996 | 52 | 0.010 |
Why?
|
| Cell Fractionation | 2 | 1978 | 68 | 0.010 |
Why?
|
| Cartilage | 1 | 1997 | 128 | 0.010 |
Why?
|
| Chickens | 1 | 1997 | 523 | 0.010 |
Why?
|
| Lymphoma | 1 | 1985 | 1467 | 0.010 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 1996 | 35 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1997 | 226 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1996 | 385 | 0.010 |
Why?
|
| Fructose Intolerance | 1 | 1976 | 4 | 0.010 |
Why?
|
| Lung Injury | 1 | 1998 | 131 | 0.010 |
Why?
|
| Viral Structural Proteins | 1 | 1996 | 47 | 0.010 |
Why?
|
| Ifosfamide | 1 | 1997 | 344 | 0.010 |
Why?
|
| Galactosemias | 1 | 1976 | 17 | 0.010 |
Why?
|
| Lens, Crystalline | 1 | 1997 | 155 | 0.010 |
Why?
|
| Ophthalmoplegia | 1 | 1976 | 79 | 0.010 |
Why?
|
| Glycogen Synthase | 1 | 1995 | 8 | 0.010 |
Why?
|
| Trigeminal Nerve | 1 | 1975 | 15 | 0.010 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 1995 | 21 | 0.010 |
Why?
|
| Uncoupling Protein 1 | 1 | 1995 | 33 | 0.010 |
Why?
|
| Bile | 1 | 1976 | 81 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 1997 | 229 | 0.010 |
Why?
|
| Facial Paralysis | 1 | 1976 | 60 | 0.010 |
Why?
|
| Anemia, Hemolytic | 1 | 1976 | 53 | 0.010 |
Why?
|
| Glucuronidase | 1 | 1995 | 48 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1976 | 101 | 0.010 |
Why?
|
| Pulmonary Artery | 2 | 1971 | 499 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1992 | 1203 | 0.010 |
Why?
|
| Chondrodysplasia Punctata | 1 | 1975 | 16 | 0.010 |
Why?
|
| Osteogenesis | 1 | 1997 | 271 | 0.010 |
Why?
|
| Streptozocin | 1 | 1995 | 75 | 0.010 |
Why?
|
| Neoplasms, Gonadal Tissue | 1 | 1994 | 3 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1995 | 120 | 0.010 |
Why?
|
| C-Peptide | 1 | 1995 | 107 | 0.010 |
Why?
|
| Tricuspid Valve | 2 | 1973 | 68 | 0.010 |
Why?
|
| Adipose Tissue, Brown | 1 | 1995 | 112 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 1996 | 406 | 0.010 |
Why?
|
| Ketones | 1 | 1995 | 54 | 0.010 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 1994 | 35 | 0.010 |
Why?
|
| Neurons | 1 | 2006 | 2287 | 0.010 |
Why?
|
| Wolffian Ducts | 1 | 1994 | 24 | 0.010 |
Why?
|
| DNA Probes | 1 | 1995 | 217 | 0.010 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1975 | 89 | 0.010 |
Why?
|
| Colforsin | 1 | 1994 | 59 | 0.010 |
Why?
|
| Infant Food | 1 | 1975 | 89 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1999 | 1144 | 0.010 |
Why?
|
| Follistatin | 1 | 1994 | 55 | 0.010 |
Why?
|
| Microinjections | 1 | 1994 | 96 | 0.010 |
Why?
|
| Oviducts | 1 | 1994 | 149 | 0.010 |
Why?
|
| Cerebellar Neoplasms | 1 | 1979 | 434 | 0.010 |
Why?
|
| Buffers | 1 | 1994 | 44 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1995 | 266 | 0.010 |
Why?
|
| Ion Channels | 1 | 1995 | 212 | 0.010 |
Why?
|
| Galactose | 1 | 1994 | 87 | 0.010 |
Why?
|
| Germ Cells | 1 | 1996 | 335 | 0.010 |
Why?
|
| Pulmonary Valve | 2 | 1973 | 87 | 0.010 |
Why?
|
| Olfactory Bulb | 1 | 1975 | 119 | 0.010 |
Why?
|
| Half-Life | 1 | 1994 | 259 | 0.010 |
Why?
|
| Giant Cells | 1 | 1994 | 69 | 0.010 |
Why?
|
| Brazil | 1 | 1974 | 165 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1994 | 110 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 362 | 0.010 |
Why?
|
| Whole Blood Coagulation Time | 1 | 1993 | 16 | 0.010 |
Why?
|
| Dwarfism | 1 | 1975 | 109 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1994 | 255 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 1994 | 69 | 0.010 |
Why?
|
| Hepatic Encephalopathy | 1 | 1994 | 66 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1999 | 1688 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1998 | 442 | 0.010 |
Why?
|
| Warfarin | 1 | 1975 | 152 | 0.010 |
Why?
|
| Partial Thromboplastin Time | 1 | 1993 | 55 | 0.010 |
Why?
|
| Remission Induction | 1 | 2000 | 3569 | 0.010 |
Why?
|
| Heart Rate, Fetal | 1 | 1993 | 51 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1993 | 25 | 0.010 |
Why?
|
| Ovariectomy | 1 | 1994 | 330 | 0.010 |
Why?
|
| Face | 3 | 1986 | 273 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1976 | 417 | 0.010 |
Why?
|
| Proviruses | 1 | 1992 | 21 | 0.010 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 1973 | 45 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1997 | 769 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1993 | 159 | 0.010 |
Why?
|
| Muscles | 1 | 1994 | 416 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 1995 | 369 | 0.010 |
Why?
|
| Survivors | 1 | 1999 | 1031 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1993 | 123 | 0.010 |
Why?
|
| Hydroxysteroids | 1 | 1972 | 2 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1037 | 0.010 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 1976 | 261 | 0.010 |
Why?
|
| Cognition | 1 | 1999 | 968 | 0.010 |
Why?
|
| Calcitriol | 1 | 1993 | 127 | 0.010 |
Why?
|
| Thyroid Diseases | 1 | 1993 | 85 | 0.010 |
Why?
|
| Femur | 1 | 1993 | 158 | 0.010 |
Why?
|
| Pregnenolone | 1 | 1971 | 5 | 0.010 |
Why?
|
| JC Virus | 1 | 1992 | 43 | 0.010 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1972 | 45 | 0.010 |
Why?
|
| Centrifugation | 1 | 1971 | 66 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 1 | 1972 | 97 | 0.010 |
Why?
|
| Tritium | 1 | 1971 | 200 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1996 | 15694 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 1971 | 38 | 0.010 |
Why?
|
| Microsomes | 1 | 1971 | 61 | 0.010 |
Why?
|
| Heart Septum | 1 | 1971 | 54 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 997 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1975 | 393 | 0.010 |
Why?
|
| NAD | 1 | 1971 | 89 | 0.010 |
Why?
|
| NADP | 1 | 1971 | 96 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 1991 | 33 | 0.010 |
Why?
|
| Ulnar Nerve | 1 | 1971 | 21 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1973 | 193 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 1991 | 35 | 0.010 |
Why?
|
| Spinal Nerve Roots | 1 | 1971 | 65 | 0.010 |
Why?
|
| Aneurysm | 1 | 1971 | 94 | 0.010 |
Why?
|
| BK Virus | 1 | 1992 | 123 | 0.010 |
Why?
|
| Brain Stem | 3 | 1976 | 175 | 0.010 |
Why?
|
| Schwann Cells | 1 | 1971 | 75 | 0.010 |
Why?
|
| Bronchial Neoplasms | 1 | 1991 | 79 | 0.010 |
Why?
|
| Vitamin A | 1 | 1991 | 94 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1971 | 333 | 0.010 |
Why?
|
| Cyanides | 1 | 1970 | 14 | 0.010 |
Why?
|
| Diterpenes | 1 | 1991 | 111 | 0.010 |
Why?
|
| Mexico | 1 | 1991 | 259 | 0.010 |
Why?
|
| Cardiac Catheterization | 2 | 1973 | 687 | 0.010 |
Why?
|
| Urogenital Neoplasms | 1 | 1991 | 108 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1992 | 1082 | 0.010 |
Why?
|
| Taste | 1 | 1970 | 50 | 0.010 |
Why?
|
| Brain | 2 | 1993 | 4113 | 0.010 |
Why?
|
| Tretinoin | 1 | 1993 | 623 | 0.010 |
Why?
|
| Splenectomy | 1 | 1991 | 158 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1971 | 190 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 1971 | 149 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1995 | 1234 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1995 | 1385 | 0.010 |
Why?
|
| Tongue | 1 | 1970 | 77 | 0.010 |
Why?
|
| Peptides | 1 | 1996 | 1479 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1991 | 235 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1971 | 426 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1975 | 526 | 0.010 |
Why?
|
| Cleft Lip | 3 | 1976 | 127 | 0.010 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 1995 | 992 | 0.010 |
Why?
|
| Pregnancy, Animal | 1 | 1970 | 92 | 0.010 |
Why?
|
| Cobalt Isotopes | 1 | 1969 | 6 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1972 | 436 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1969 | 132 | 0.010 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 1989 | 18 | 0.010 |
Why?
|
| Pelvis | 1 | 1971 | 362 | 0.010 |
Why?
|
| Shwartzman Phenomenon | 1 | 1968 | 1 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1969 | 52 | 0.010 |
Why?
|
| Pyrogens | 1 | 1968 | 5 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1989 | 629 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1971 | 260 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1968 | 241 | 0.010 |
Why?
|
| Aerosols | 1 | 1969 | 158 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1992 | 1869 | 0.010 |
Why?
|
| Hematocrit | 1 | 1968 | 142 | 0.010 |
Why?
|
| Blood Coagulation Factors | 1 | 1968 | 59 | 0.010 |
Why?
|
| Cytarabine | 1 | 1974 | 1973 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 1968 | 87 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 1968 | 103 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1991 | 340 | 0.010 |
Why?
|
| Digestive System | 1 | 1988 | 114 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 1648 | 0.000 |
Why?
|
| Microvilli | 1 | 1987 | 83 | 0.000 |
Why?
|
| Immunization, Passive | 1 | 1968 | 172 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 117 | 0.000 |
Why?
|
| Swine, Miniature | 1 | 1987 | 67 | 0.000 |
Why?
|
| Informed Consent | 1 | 1991 | 419 | 0.000 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1987 | 84 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1993 | 1467 | 0.000 |
Why?
|
| Mast Cells | 1 | 1969 | 223 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1968 | 205 | 0.000 |
Why?
|
| Mesonephroma | 1 | 1986 | 17 | 0.000 |
Why?
|
| Sclerosis | 1 | 1987 | 84 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1971 | 665 | 0.000 |
Why?
|
| Xylose | 1 | 1986 | 19 | 0.000 |
Why?
|
| RNA | 1 | 1971 | 1013 | 0.000 |
Why?
|
| Heart Failure | 2 | 1978 | 2516 | 0.000 |
Why?
|
| Polyhydramnios | 1 | 1986 | 36 | 0.000 |
Why?
|
| Ascitic Fluid | 1 | 1986 | 76 | 0.000 |
Why?
|
| Amniocentesis | 1 | 1986 | 76 | 0.000 |
Why?
|
| Lipids | 1 | 1970 | 644 | 0.000 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1985 | 18 | 0.000 |
Why?
|
| Chemical Fractionation | 1 | 1985 | 27 | 0.000 |
Why?
|
| Permeability | 1 | 1986 | 167 | 0.000 |
Why?
|
| Macrophage-1 Antigen | 1 | 1985 | 51 | 0.000 |
Why?
|
| Cell Aggregation | 1 | 1985 | 61 | 0.000 |
Why?
|
| China | 1 | 1987 | 606 | 0.000 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1985 | 84 | 0.000 |
Why?
|
| Receptors, Complement | 1 | 1985 | 48 | 0.000 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1985 | 72 | 0.000 |
Why?
|
| Celiac Disease | 1 | 1986 | 75 | 0.000 |
Why?
|
| Technetium | 1 | 1985 | 77 | 0.000 |
Why?
|
| Pulmonary Veins | 1 | 1967 | 174 | 0.000 |
Why?
|
| Germ-Free Life | 1 | 1985 | 69 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1985 | 139 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 568 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1991 | 1529 | 0.000 |
Why?
|
| Infant, Low Birth Weight | 1 | 1985 | 181 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1985 | 548 | 0.000 |
Why?
|
| Cricetinae | 1 | 1965 | 706 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 660 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1985 | 1062 | 0.000 |
Why?
|
| Cell Adhesion | 1 | 1985 | 1008 | 0.000 |
Why?
|
| Myocardium | 1 | 1969 | 1313 | 0.000 |
Why?
|
| Sepsis | 1 | 1968 | 652 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1967 | 712 | 0.000 |
Why?
|
| Nephrectomy | 1 | 1986 | 779 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1991 | 3719 | 0.000 |
Why?
|
| Texas | 1 | 1991 | 6311 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1978 | 43 | 0.000 |
Why?
|
| Hemocyanins | 1 | 1978 | 50 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1991 | 3341 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1985 | 2358 | 0.000 |
Why?
|
| Trochlear Nerve | 1 | 1976 | 1 | 0.000 |
Why?
|
| Abducens Nerve | 1 | 1976 | 9 | 0.000 |
Why?
|
| Pain Insensitivity, Congenital | 1 | 1975 | 1 | 0.000 |
Why?
|
| Facial Nerve | 1 | 1976 | 64 | 0.000 |
Why?
|
| Hypertelorism | 1 | 1975 | 14 | 0.000 |
Why?
|
| Cranial Nerves | 1 | 1975 | 20 | 0.000 |
Why?
|
| Ear, External | 1 | 1975 | 42 | 0.000 |
Why?
|
| Sulfisoxazole | 1 | 1975 | 2 | 0.000 |
Why?
|
| Digitoxin | 1 | 1975 | 13 | 0.000 |
Why?
|
| Dermoid Cyst | 1 | 1975 | 38 | 0.000 |
Why?
|
| Hematopoietic System | 1 | 1974 | 26 | 0.000 |
Why?
|
| Orbit | 1 | 1976 | 205 | 0.000 |
Why?
|
| Digoxin | 1 | 1975 | 63 | 0.000 |
Why?
|
| Hair | 1 | 1974 | 42 | 0.000 |
Why?
|
| Placenta Diseases | 1 | 1975 | 56 | 0.000 |
Why?
|
| Eye | 1 | 1976 | 301 | 0.000 |
Why?
|
| Arm | 1 | 1975 | 147 | 0.000 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 1973 | 11 | 0.000 |
Why?
|
| Bone Diseases | 1 | 1975 | 143 | 0.000 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1973 | 17 | 0.000 |
Why?
|
| Leg | 1 | 1975 | 226 | 0.000 |
Why?
|
| Heart Valves | 1 | 1973 | 66 | 0.000 |
Why?
|
| Eye Neoplasms | 1 | 1975 | 247 | 0.000 |
Why?
|
| Heparin | 1 | 1975 | 360 | 0.000 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1973 | 137 | 0.000 |
Why?
|
| Mitral Valve | 1 | 1973 | 271 | 0.000 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1973 | 180 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1974 | 403 | 0.000 |
Why?
|
| Retina | 1 | 1974 | 532 | 0.000 |
Why?
|
| Cerebellum | 1 | 1974 | 449 | 0.000 |
Why?
|
| Heart Valve Prosthesis | 1 | 1975 | 386 | 0.000 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1970 | 122 | 0.000 |
Why?
|
| Aortic Valve | 1 | 1973 | 581 | 0.000 |
Why?
|